Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Acute VTE
NCT02331095Phase 1Terminated
- Sponsor
- The Ohio State University
- Start
- Jan 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin in venous thromboembolism (VTE) (2 arms), sponsored by The Ohio State University. Primary endpoints: Reduction of Endogenous Thrombin Potential at 3 months and Reduction of Peak Thrombin Concentration at 3 months. Started Jan 2015; status: terminated.
02
Drugs
atorvastatin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02331095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331095.